Abstract Somatic mutations within a mononucleotide repeat sequence present in the hMSH6 and hMSH3 coding regions have been frequently observed in various human cancer tissues and cell lines showing genomic instability. However, relatively few germline mutations of the repeat sequence have been identified. Two germline mutations in the hMSH6 region have been reported in hereditary nonpolyposis colorectal cancer (HNPCC); however, no germline mutations in the hMSH3 gene have been reported yet. To investigate genetic alterations within an 8 bp polycytosine repeat of the hMSH6 gene and an 8-bp polyadenine repeat of the hMSH3 gene, we amplified the mononucleotide repeat sequences of 35 HNPCC patients, 44 patients suspected of having HNPCC who did not fulfill the criteria of the International Collaborative Group on HNPCC, and 45 patients with sporadic early-onset colorectal cancer who developed colorectal cancer before the age of 40 years without any family history of colorectal cancer. Genetic alteration of the repeat sequence of the hMSH3 gene was not observed, whereas germline frameshift mutations (one C insertion) in the hMSH6 gene were found in two of the 44 suspected HNPCC patients in whom germline mutations of hMSH2 or hMLH1 had not been detected. An identical frameshift mutation was also observed in another affected member of a suspected HNPCC family. These results suggest that the mutation of hMSH6 is responsible for tumorigenesis in minor groups of suspected HNPCC patients.
Introduction
Hereditary nonpolyposis colorectal cancer (HNPCC) is the most common hereditary condition predisposing patients to the development of colorectal cancer. Germline mutations in genes of the mismatch repair (MMR) system, namely hMSH2, hMLH1, hPMS1, and hPMS2, have been identified in patients with HNPCC (Fishel et al. 1993; Bronner et al. 1994; Liu et al. 1994; Nicolaides et al. 1994; Han et al. 1996) . Defective MMR is associated with alterations in microsatellite sequences, indicating genomic instability.
Two other MMR genes, hMSH6 (also known as GTBP) and hMSH3, which are also involved in the MMR pathway have been cloned as bacterial mutS homologs (Drummond et al. 1995; Palombo et al. 1995) . Somatic mutations in the hMSH6 and hMSH3 genes, especially at mononucleotide repeat sequences, have been observed in HNPCC, sporadic colorectal, and gastric carcinomas showing genomic instability (Akiyama et al. 1997b; Yamamoto et al. 1997; Yin et al. 1997) . Most of the mutations found were additions or deletions of the mononucleotide repeat sequences present in the hMSH3 and hMSH6 coding regions. This observation suggested that these genes may be the target genes of the genomic instability in tumorigenesis. Recently, germline mutations in hMSH6 were reported (Akiyama et al. 1997b; Miyaki et al. 1997) . Our previous studies demonstrating a relatively low incidence of mutation in the hMSH2 and hMLH1 genes in HNPCC patients have indicated the possibility of genetic alterations in other MMR genes (Han et al. 1996; Yuan et al. 1998) .
Therefore, to clarify whether or not germline mutation in the repeat sequences of hMSH6 and hMSH3 is implicated in tumorigenesis, we screened 35 HNPCC patients satisfying the International Collaborative Group on HNPCC (ICG-HNPCC) criteria, and 44 suspected HNPCC patients. We previously proposed the term "suspected HNPCC" for families who do not fulfill the ICG-HNPCC criteria but in whom a genetic basis for colon cancer is strongly suspected (Han et al. 1996; Yuan et al. 1998 ). These families were registered according to the suggested criteria:
Ki-Hyuk Shin · Ja-Lok Ku · Jae-Gahb Park Germline mutations in a polycytosine repeat of the hMSH6 gene in Korean hereditary nonpolyposis colorectal cancer (Han et al. 1996) d Thirty-one cases were previously reported (Han et al. 1996; Yuan et al. 1998) e Forty-five cases were previously reported (Han et al. 1996; Yuan et al. 1998) (1) vertical transmission of colorectal cancer or at least two siblings affected with colorectal cancer in a family; (2) development of multiple colorectal tumors or at least one colorectal cancer diagnosed before the age of 50 years. A 20% mutational frequency of the hMSH2 and hMLH1 genes was identified in our study of 44 suspected HNPCC patients, including the previous reported 31 suspected HNPCC patients (Table 1) . Forty-five early-onset colorectal cancer patients who developed colorectal cancer before the age of 40 years without any family history of colorectal cancer were also examined.
Materials and methods

Subjects and DNA isolation from blood samples
Including the previously reported samples, 35 HNPCC, 44 suspected HNPCC, and 45 sporadic early-onset colorectal cancer patients registered in the Korean Hereditary Colorectal Cancer Registry were used in this study (Han et al. 1996; Yuan et al. 1998) . Between 20 ml and 30 ml of peripheral blood from each patient was used to prepare genomic DNA from white blood cells, as described elsewhere (Blin et al. 1976 ).
Analysis of the mononucleotide repeat sequences in hMSH6 and hMSH3
We analyzed frameshift mutations in the repeat sequences by modified polymerase chair reaction -single-strand conformation polymorphism (PCR-SSCP). The PCR primers were sense (5Ј-TGA CTG ATA CTT CTA CCA GC-3Ј) and antisense (5Ј-AAC ATT TGT TCC TCA CCT GC-3Ј) for the 8-bp polyadenine repeat in exon 7 of the hMSH3 gene and sense (5Ј-GGG TGA TGG TCC TAT GTG TC-3Ј) and antisense (5Ј-CGT AAT GCA AGG ATG GCG T-3Ј) for the 8-bp polycytosine repeat in exon 5 of the hMSH6 gene. The repeat sequences were amplified from 100 ng of genomic DNA using the sense primer of each gene labeled with [γ-32 P]dATP using T4 polynucleotide kinase and the unlabeled antisense primer of each gene. The PCR condition consisted of 35 cycles at 95°C for 30s, 45°C for 1 min, and 70°C for 1 min. The PCR products were denatured, separated on 7% polyacrylamide gels on 60W constant, and visualized by autoradiography.
DNA sequencing analysis
When abnormal patterns were detected by PCR-SSCP analysis, the PCR products were purified with QIAquick PCR purification kit (Qiagen, Inc., Chatsworth, CA, USA) and then sequenced directly with a Taq dideoxy terminator cycle sequencing kit on an ABI 377 automatic DNA sequencer (Perkin-Elmer, Foster city, CA, USA).
Results and discussion
PCR-SSCP analysis of the mononucleotide repeat sequence in hMSH3 did not detect an abnormal band pattern. However, the analysis of the hMSH6 gene revealed abnormal bands from the DNAs of two suspected HNPCC patients (SNU-H1005 and SNU-H1047) in which germline mutations of hMSH2 and hMLH1 could not be detected (Figs 1a and 2a) . In the SNU-H1005 and the SNU-H1047 patients, subsequent sequencing analysis of the hMSH6 gene revealed one C insertion at codons 1085-1087, predicting a premature stop codon in codon 1092 (Figs 1c and 2b ). This germline mutation was identical to the previously reported germline mutation found in an HNPCC-like patient (Akiyama et al. 1997a ). Patient SNU-H1005 was diagnosed as having rectal cancer at the age of 37 years. Although the SNU-H1005 family did not meet the ICG-HNPCC criteria, two of the seven siblings were diagnosed as having colorectal cancer (also, their father had died of gastric cancer). Because the blood of the brother of the affected family member was not available, we could not examine the mutation at the repeat sequence. However, the mutation was not detected in the normal members (his two sisters). Patient SNU-H1047 had rectal cancer at 37 years of age, and his mother was also diagnosed with colorectal cancer at 67 years of age. We tested for the mutation at the polycytosine repeat sequence in hMSH6 from the genomic DNAs of his mother and two normal family members (his daughter and his mother's sister). An identical frameshift mutation to that found in SNU-H1047 was detected only in the DNA of his mother (data not shown). Since germline An abnormal band pattern was detected in normal cells from patient SNU-H1047. b Sequencing analysis of the repeat sequence of hMSH6 in SNU-H1047. A heterozygous one-C insertion was found mutations in the hMSH2 and hMLH1 genes were not detected, and a functionally inactive mutation of hMSH6 was found only in the affected family members, we concluded that frameshift mutation of the hMSH6 gene is pathogenic in the tumorigenesis of these families.
Although mutation screening was performed in a very limited area of the hMSH6 gene, the mutation frequency (4.5%) of the gene was the same as that of hMSH2 in which all the exons were examined by PCR-SSCP analysis in 44 suspected HNPCC patients (Table 1) . Since a germline mutation outside the repeat sequence of the hMSH6 gene was found in an HNPCC kindred (Miyaki et al. 1997) , the entire coding sequence of the hMSH6 gene is under investigation in our samples. Our results suggest that genetic testing for the hMSH6 gene should be required in HNPCC and suspected HNPCC patients without germline mutations of the hMSH2 and hMLH1 genes.
